O-Glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines
The DOI matches its Crossref record; 51 of the 54 references it cites were found in a registry or an index.
Abstract
Our studies provide direct evidence that O-glycosylation pathways play a role in the regulation of cell growth through apoptosis and proliferation pathways. A series of small molecular weight analogs of the GalNAc-alpha-1-O-serine/threonine structure based on 1-benzyl-2-acetamido-2-deoxy-alpha-O-d-galactopyranoside have been synthesized and tested in the human colorectal cancer cell lines PC/AA/C1/SB10C and HCA7/C29. Three inhibitors, 1-benzyl-2-acetamido-2-deoxy-alpha-O-D-galactopyranoside, and the corresponding 2-azido- and C-glycoside analogs were screened in these colorectal cancer cell lines at 0.5 mM and showed induction of apoptosis and downregulation of proliferation. Treatment of both cell lines with inhibitors led to changes in glycosylation detected with peanut lectin. The inhibition of glycosyltransferase activity in cell homogenates from human colorectal mucosal cells and cultured cell lines could be shown. The competitive action of the inhibitors resulted in the intracellular formation of 28 aryl-glycan products which were identified by MALDI and electrospray mass spectroscopy. The structures showed a differential pattern for each of the inhibitors in both cell lines. Gene array analysis of the glycogenes illustrated a pattern of glycosyltransferases that matched the glycan structures found in glycoproteins and aryl-glycans formed in the PC/AA/C1/SB10C cells; however, there was no action of the three inhibitors on glycogene transcript levels. The inhibitors act at both intermediary metabolic and genomic levels, resulting in altered protein glycosylation and aryl-glycan formation. These events may play a part in growth arrest.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
Dube, D. H., & Bertozzi, C. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1751 · Cited by 1,598
The sweet and sour of cancer: glycans as novel therapeutic targets
Fuster, M. M., & Esko, J. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1649 · Cited by 1,383 · cited 3×
“Glycosylation of cellular and membrane proteins includes N - and O -linked glycoproteins, proteoglycans, and glycosylphosphatidylinositol (GPI) anchors (Schachter and Brockhausen 1992; Fuster and Esko 2005).”
BackgroundModulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,236
Mucins in the mucosal barrier to infection
Linden, S. K., Sutton, P., Karlsson, N. G., Korolik, V, & McGuckin, M. A. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.5 · Cited by 1,234 · cited 2×
“The mucin-type Oglycan chains are linked to serine and threonine through an α-O-glycosyl linkage to N-acetylgalactosamine in well-defined core structures (Corfield et al. 2001; Linden et al. 2008).”
BackgroundChemical remodelling of cell surfaces in living animals
Prescher, J. A., Dube, D. H., & Bertozzi, C. R. (2004) · Nature · doi:10.1038/nature02791 · Cited by 842 · cited 4×
“2000), and studies with other glycosylation inhibitors have employed peracetylated derivatives to improve uptake (Sarkar et al. 2000; Prescher et al. 2004; Dube and Bertozzi 2005).”
BackgroundInfluentialStructure and Function of the Polymeric Mucins in Airways Mucus
Thornton, D. J., Rousseau, K., & McGuckin, M. A. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100702 · Cited by 823 · cited 2×
“The mucin-type O-glycans are abundant as components of the mucosal protective barrier and are also found in a variety of other proteins (Corfield et al. 2001; Thornton et al. 2008).”
BackgroundConcepts and Principles of O-Linked Glycosylation
Steen, P. V. D., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (1998) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239891204198 · Cited by 760 · cited 1×
“The surface membranes of mammalian cells are rich in gly-coconjugates which mediate many cellular events and are intimately involved in cell–cell and cell–matrix interactions (Van den Steen et al. 1998).”
BackgroundHague, A., Manning, A. M., Hanlon, K. A., Hart, D., Paraskeva, C., & Huschtscha, L. I. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550329 · Cited by 530 · cited 9×
“Shed cells were confirmed as apoptotic using a combination of biochemical and morphological assays as described previously by us and others (Hague et al. 1993; Sheng et al. 1998; Diaz et al. 2000).”
BackgroundMethodResultInfluentialSelf-citationBrewer, C. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00364-0 · Cited by 435 · cited 2×
“2004; Dube and Bertozzi 2005) and cell signalling through multivalent protein–glycan networks mediated by galectins (Brewer et al. 2002; Gabius 2006), implicating roles in cell and tissue development and viability.”
BackgroundMucins in the gastrointestinal tract in health and disease
Corfield, A. (2001) · Frontiers in Bioscience · doi:10.2741/corfield · Cited by 344 · cited 2×
“The mucin-type Oglycan chains are linked to serine and threonine through an α-O-glycosyl linkage to N-acetylgalactosamine in well-defined core structures (Corfield et al. 2001; Linden et al. 2008).”
Background
Research works printed but not linked: 1
- Schachter, 1992, The biosynthesis of serine (threonine)-N-acetylgalactosamine-linked carbohydrate moieties, 263
Cited by
A glycobiology review: Carbohydrates, lectins and implications in cancer therapeutics
Ghazarian, H., Idoni, B., & Oppenheimer, S. B. (2011) · Acta Histochemica · doi:10.1016/j.acthis.2010.02.004 · Cited by 433
“Here, the C-1 of N-acetylgalactosamine is covalently bonded to the hydroxyl of serine or threonine of the target polypeptide chain (core protein) (Rottger et al., 1998; Patsos et al., 2009).”
BackgroundInfluentialGlycosylation Characteristics of Colorectal Cancer
Holst, S., Wuhrer, M., & Rombouts, Y. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.11.004 · Cited by 173
Drug resistance related to aberrant glycosylation in colorectal cancer
Very, N., Lefebvre, T., & Yazidi‐Belkoura, I. E. (2017) · Oncotarget · doi:10.18632/oncotarget.22377 · Cited by 122
“Treatment of CRC cells with benzyl-2-acetamido2-deoxy-α-D-galactopyranoside (benzyl-α-GalNAc), a structural analog of α-GalNAc linked to serine or threonine residue which competitively inhibits core 1 O-glycans extension, or benzyl-α-GalNAc-derived oligosaccharides has been shown to induce apoptosis [112] and reduce s…”
BackgroundHarvey, D. J. (2010) · Mass Spectrometry Reviews · doi:10.1002/mas.20265 · Cited by 105
Ferreira, J. A., Magalhães, A., Gomes, J., Peixoto, A., Gaiteiro, C., Fernandes, E., Santos, L. L., & Reis, C. A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.044 · Cited by 107
Metadata
- Authors
- Patsos, G., Hebbe-Viton, V., Robbe-Masselot, C., Masselot, D., Martin, R. S., Greenwood, R., Paraskeva, C., Klein, A., Graessmann, M., Michalski, J. C., Gallagher, T., & Corfield, A.
- Affiliations
- University of Bristol (GB)
- Charité – Universitätsmedizin Berlin (DE)
- Centre National de la Recherche Scientifique (FR)
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01-03
- Volume
- 19
- Issue
- 4
- Pages
- 382-398
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- OpenAlex
- W2106498299
- Cited by
- 68
- References
- 54
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 29 · 2023: 1 · 2022: 3 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 7 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Glycobiology (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- Explore Bristol Research (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Biotechnology and Biological Sciences Research Council (B19303)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Physical Sciences › Chemistry › Organic Chemistry › Natural product bioactivities and synthesis
- Keywords
- glycosyltransferase inhibition, apoptosis, colorectal cancer cell lines, cell growth inhibition, protein glycosylation, C-glycosides, growth arrest
- MeSH terms
- Drug Screening Assays, Antitumor, Enzyme Inhibitors, Galactose, Glycoproteins, Glycosylation, Humans, Neoplasm Proteins, Colorectal Neoplasms, Glycosyltransferases, Apoptosis, Caco-2 Cells, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: O-Glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines. https://app.cochat.ai/papers/10.1093/glycob/cwn149
- The paper
- Patsos, G., Hebbe-Viton, V., Robbe-Masselot, C., Masselot, D., Martin, R. S., Greenwood, R., Paraskeva, C., Klein, A., Graessmann, M., Michalski, J. C., Gallagher, T., & Corfield, A. (2009). O-Glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines. Glycobiology. https://doi.org/10.1093/glycob/cwn149
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.